cimetidine has been researched along with Dysmyelopoietic Syndromes in 2 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisenberg, S | 1 |
| Gurzó, M | 1 |
| Varga, G | 1 |
| Dobos, K | 1 |
| Náfrádi, J | 1 |
| Petri, A | 1 |
2 other studies available for cimetidine and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
The case of the horrible hives.
Topics: Cimetidine; Diphenhydramine; Erythrocyte Transfusion; Histamine H1 Antagonists; Histamine H2 Antagon | 2011 |
[Therapeutic possibilities in the management of gastrointestinal bleeding in thrombocytopenic patients].
Topics: Aged; Blood Coagulation Disorders; Blood Transfusion; Cimetidine; Ethamsylate; Gastrointestinal Hemo | 1994 |